Shuttle Pharmaceuticals Holdings, Inc. Income Statement

Income Statement Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.05M-0.92M-2.48M-1.20M
Operating items
Research & Development 1.02M1.15M3.52M3.62M
Selling, General & Administrative 0.04M0.54M1.05M1.39M
Other Operating Expenses 0.68M0.87M1.33M2.68M
Operating Expenses 1.74M2.55M5.89M7.70M
Operating Income -1.74M-2.55M-5.89M-7.70M
EBIT -1.74M-2.55M-5.89M-7.70M
Non-operating items
Non Operating Investment Income 0.07M
Interest & Investment Income 0.08M0.04M
Other Non Operating Income 0.33M2.22M0.56M
Non Operating Income 0.59M-0.47M-0.70M-1.45M
Net income details
EBT -1.15M-3.03M-6.59M-8.86M
Profit After Tax -1.15M-3.03M-6.59M-9.14M
Income from Continuing Operations -1.15M-3.03M-6.59M-8.86M
Consolidated Net Income -1.15M-3.03M-6.59M-8.86M
Income towards Parent Company -1.15M-3.03M-6.59M-8.86M
Preferred Dividend Payments 0.10M0.07M
Net Income towards Common Stockholders -1.26M-3.10M-6.59M-8.86M
Additional items
EPS (Basic) -0.12-0.29-3.53-3.19
EPS (Weighted Average and Diluted) -0.29-3.53-3.30
Shares Outstanding (Weighted Average) 0.07M0.07M0.08M0.15M
EBITDA -1.74M-2.55M-5.89M-7.70M
Interest Expenses 0.05M0.92M2.48M1.20M